---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-028823"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2026-06-16T12:30:22+00:00"
generated_at: "2026-06-16T12:35:19.959210+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Technologies to host veteran lung cancer webinar July 21, 2026

## Summary
- Webinar features Philips, 4DMedical, and NAVREF discussing lung health screening for veterans.
- CyPath Lung test cited: 92% sensitivity, 87% specificity, 99% NPV in published trial.
- Event is educational; no financial guidance or operational updates provided.
- No changes to company outlook or product commercialization disclosed.

## SEC filing metadata
- accession: 0001493152-26-028823
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2026-06-16T12:30:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315226028823/0001493152-26-028823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315226028823/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-028823
- JSON: https://secwatch.observer/filing/0001493152-26-028823.json
- Plain text: https://secwatch.observer/filing/0001493152-26-028823.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.